165 related articles for article (PubMed ID: 36860929)
1. Platycodin D confers oxaliplatin Resistance in Colorectal Cancer by activating the LATS2/YAP1 axis of the hippo signaling pathway.
Wang CH; Baskaran R; Ng SS; Wang TF; Li CC; Ho TJ; Hsieh DJ; Kuo CH; Chen MC; Huang CY
J Cancer; 2023; 14(3):393-402. PubMed ID: 36860929
[TBL] [Abstract][Full Text] [Related]
2. Platycodin D sensitizes
Liu Y; Tian S; Yi B; Feng Z; Chu T; Liu J; Zhang C; Zhang S; Wang Y
Front Oncol; 2022; 12():1046143. PubMed ID: 36387129
[TBL] [Abstract][Full Text] [Related]
3. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
[TBL] [Abstract][Full Text] [Related]
4. FOXC1 Regulation of miR-31-5p Confers Oxaliplatin Resistance by Targeting LATS2 in Colorectal Cancer.
Hsu HH; Kuo WW; Shih HN; Cheng SF; Yang CK; Chen MC; Tu CC; Viswanadha VP; Liao PH; Huang CY
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31623173
[TBL] [Abstract][Full Text] [Related]
5. Myosin light chain 9 promotes the proliferation, invasion, migration and angiogenesis of colorectal cancer cells by binding to Yes-associated protein 1 and regulating Hippo signaling.
Feng M; Dong N; Zhou X; Ma L; Xiang R
Bioengineered; 2022 Jan; 13(1):96-106. PubMed ID: 34974798
[TBL] [Abstract][Full Text] [Related]
6. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
Chun J; Kim YS
Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
[TBL] [Abstract][Full Text] [Related]
7. Blockade of a novel MAP4K4-LATS2-SASH1-YAP1 cascade inhibits tumorigenesis and metastasis in luminal breast cancer.
Yang P; Li Y; Hou J; Wu D; Zeng X; Zeng Z; Zhang J; Xiong Y; Chen L; Yang D; Wan X; Wu Z; Jia L; Liu Q; Lu Q; Zou X; Fang W; Zeng X; Zhou D
J Biol Chem; 2024 Apr; 300(6):107309. PubMed ID: 38657867
[TBL] [Abstract][Full Text] [Related]
8. MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis.
Sun Z; Zhang Q; Yuan W; Li X; Chen C; Guo Y; Shao B; Dang Q; Zhou Q; Wang Q; Wang G; Liu J; Kan Q
J Exp Clin Cancer Res; 2020 Nov; 39(1):250. PubMed ID: 33218358
[TBL] [Abstract][Full Text] [Related]
9. Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration through p53.
Hsu HH; Kuo WW; Ju DT; Yeh YL; Tu CC; Tsai YL; Shen CY; Chang SH; Chung LC; Huang CY
World J Gastroenterol; 2014 Nov; 20(44):16665-73. PubMed ID: 25469035
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway.
Hu D; Meng RY; Nguyen TV; Chai OH; Park BH; Lee JS; Kim SM
Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36382656
[TBL] [Abstract][Full Text] [Related]
11. The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa.
Molina-Castro SE; Tiffon C; Giraud J; Boeuf H; Sifre E; Giese A; Belleannée G; Lehours P; Bessède E; Mégraud F; Dubus P; Staedel C; Varon C
Cell Mol Gastroenterol Hepatol; 2020; 9(2):257-276. PubMed ID: 31669263
[TBL] [Abstract][Full Text] [Related]
12. Platycodin D, a triterpenoid saponin from Platycodon grandiflorum, induces G2/M arrest and apoptosis in human hepatoma HepG2 cells by modulating the PI3K/Akt pathway.
Qin H; Du X; Zhang Y; Wang R
Tumour Biol; 2014 Feb; 35(2):1267-74. PubMed ID: 24048756
[TBL] [Abstract][Full Text] [Related]
13. Platycodin D, a triterpenoid saponin from Platycodon grandiflorum, suppresses the growth and invasion of human oral squamous cell carcinoma cells via the NF-κB pathway.
Zhang Z; Zhao M; Zheng W; Liu Y
J Biochem Mol Toxicol; 2017 Sep; 31(9):. PubMed ID: 28548219
[TBL] [Abstract][Full Text] [Related]
14. LATS2-mediated YAP1 phosphorylation is involved in HCC tumorigenesis.
Guo C; Wang X; Liang L
Int J Clin Exp Pathol; 2015; 8(2):1690-7. PubMed ID: 25973055
[TBL] [Abstract][Full Text] [Related]
15. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.
Kemppainen K; Wentus N; Lassila T; Laiho A; Törnquist K
Cell Signal; 2016 Dec; 28(12):1894-1903. PubMed ID: 27634386
[TBL] [Abstract][Full Text] [Related]
16. Platycodin-D Induced Autophagy in Non-Small Cell Lung Cancer Cells via PI3K/Akt/mTOR and MAPK Signaling Pathways.
Zhao R; Chen M; Jiang Z; Zhao F; Xi B; Zhang X; Fu H; Zhou K
J Cancer; 2015; 6(7):623-31. PubMed ID: 26078792
[TBL] [Abstract][Full Text] [Related]
17. Platycodin D, a metabolite of Platycodin grandiflorum, inhibits highly metastatic MDA-MB-231 breast cancer growth in vitro and in vivo by targeting the MDM2 oncogene.
Kong Y; Lu ZL; Wang JJ; Zhou R; Guo J; Liu J; Sun HL; Wang H; Song W; Yang J; Xu HX
Oncol Rep; 2016 Sep; 36(3):1447-56. PubMed ID: 27432230
[TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis.
Hsu HH; Chen MC; Baskaran R; Lin YM; Day CH; Lin YJ; Tu CC; Vijaya Padma V; Kuo WW; Huang CY
J Cell Physiol; 2018 Jul; 233(7):5458-5467. PubMed ID: 29247488
[TBL] [Abstract][Full Text] [Related]
19. Hippo effector YAP directly regulates the expression of PD-L1 transcripts in EGFR-TKI-resistant lung adenocarcinoma.
Lee BS; Park DI; Lee DH; Lee JE; Yeo MK; Park YH; Lim DS; Choi W; Lee DH; Yoo G; Kim HB; Kang D; Moon JY; Jung SS; Kim JO; Cho SY; Park HS; Chung C
Biochem Biophys Res Commun; 2017 Sep; 491(2):493-499. PubMed ID: 28684311
[TBL] [Abstract][Full Text] [Related]
20. Reversal effect of ginsenoside Rh2 on oxaliplatin-resistant colon cancer cells and its mechanism.
Ma J; Gao G; Lu H; Fang D; Li L; Wei G; Chen A; Yang Y; Zhang H; Huo J
Exp Ther Med; 2019 Jul; 18(1):630-636. PubMed ID: 31258699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]